Literature DB >> 15065001

Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis.

Hiroaki Nohara1, Naoko Okayama, Nagamu Inoue, Yuji Koike, Kozue Fujimura, Yutaka Suehiro, Yuichiro Hamanaka, Singo Higaki, Hideo Yanai, Tomoharu Yoshida, Toshifumi Hibi, Kiwamu Okita, Yuji Hinoda.   

Abstract

BACKGROUND: Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine and has been shown to be involved in the development of chronic murine colitis. In the +173 G/C polymorphism of the MIF gene, the presence of C creates the binding motif of activator protein 4. This study explored the association of this polymorphism with ulcerative colitis (UC).
METHODS: Genotyping was carried out, with a tetra-primer polymerase chain reaction (PCR) method, for 659 DNA specimens from 438 healthy volunteers and 221 patients with UC. Genotype distribution between cases and controls and the association of patients' genotypes with clinical parameters were statistically evaluated.
RESULTS: No significant difference in genotype distribution was found between UC patients and healthy controls. However, when the relation of the C/C genotype to clinical parameters in UC patients was evaluated by Fisher's exact test, it was found that the frequency of the C/C genotype was higher in patients with pancolitis type than in those with other types restricted to the distal or left-sided colon (odds ratio [OR], 10.781; 95% confidence interval [CI], 1.342-86.619; P = 0.0074).
CONCLUSIONS: These data suggest that the MIF -173 G/C polymorphism may be related to the extent of disease in UC in a Japanese population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15065001     DOI: 10.1007/s00535-003-1284-7

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  33 in total

Review 1.  Macrophage migration inhibitory factor (MIF): a promising biomarker.

Authors:  Gerrit Grieb; Melanie Merk; Jürgen Bernhagen; Richard Bucala
Journal:  Drug News Perspect       Date:  2010-05

2.  Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease.

Authors:  J Oliver; A Márquez; M Gómez-Garcia; A Martinez; J L Mendoza; J R Vilchez; M A López-Nevot; A Piñero; E G de la Concha; A Nieto; E Urcelay; J Martín
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

Review 3.  Biliary atresia: cellular dynamics and immune dysregulation.

Authors:  Amy G Feldman; Cara L Mack
Journal:  Semin Pediatr Surg       Date:  2012-08       Impact factor: 2.754

Review 4.  Clues to the etiology of bile duct injury in biliary atresia.

Authors:  Cara L Mack; Amy G Feldman; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

5.  Association of macrophage migration inhibitory factor -173C allele polymorphism with steroid resistance in children with nephrotic syndrome.

Authors:  Afig Berdeli; Sevgi Mir; Nese Ozkayin; Erkin Serdaroglu; Yilmaz Tabel; Alphan Cura
Journal:  Pediatr Nephrol       Date:  2005-08-16       Impact factor: 3.714

6.  Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.

Authors:  Antoine Sreih; Rana Ezzeddine; Lin Leng; Avery LaChance; Geraldine Yu; Yuka Mizue; Lakshman Subrahmanyan; Bernardo A Pons-Estel; Anna-Karin Abelson; Iva Gunnarsson; Elisabet Svenungsson; Joshua Cavett; Stuart Glenn; Lin Zhang; Ruth Montgomery; Andras Perl; Jane Salmon; Marta E Alarcón-Riquelme; John B Harley; Richard Bucala
Journal:  Arthritis Rheum       Date:  2011-12

Review 7.  Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis.

Authors:  James D Falvey; Robert W Bentley; Tony R Merriman; Mark B Hampton; Murray L Barclay; Richard B Gearry; Rebecca L Roberts
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

8.  Association of the macrophage migration inhibitory factor promoter polymorphisms with benign lymphoepithelial lesion of lacrimal gland.

Authors:  Qin-Jian Li; Peng-Xiang Zhao; Xu-Juan Zhang; Yang Yi; Dan-Ying Cheng; Jian-Min Ma; Xue-Mei Ma
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

9.  A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients.

Authors:  David N Assis; Hiroki Takahashi; Lin Leng; Mikio Zeniya; James L Boyer; Richard Bucala
Journal:  Dig Dis Sci       Date:  2016-10-01       Impact factor: 3.199

10.  A MIF haplotype is associated with the outcome of patients with severe sepsis: a case control study.

Authors:  Lutz E Lehmann; Malte Book; Wolfgang Hartmann; Stefan U Weber; Jens-Christian Schewe; Sven Klaschik; Andreas Hoeft; Frank Stüber
Journal:  J Transl Med       Date:  2009-11-26       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.